fashion -WSS

fashion

author：explore 2025-09-30 16:29:20 - browse：625

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Biogen Alzheimer’s drug launch off to slow start

WSS

Micronoma's microbiome cancer diagnostic approach under fire

Mitch McConnell episode has important public health takeaway

Senators start work on Medicare physician payment reform

Senators start work on Medicare physician payment reform

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Key House Republican on health care plans exit from Congress

entertainment

fashion

entertainment

In Memoriam: Notable people who died in 2023

Senators start work on Medicare physician payment reform

Moonlake's readout produced a cash windfall. Risks remain

How digital tools helped lower hypertension in marginalized patients

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare threatens to cut off funding for HCA's Mission hospital

After affirmative action ruling, medical educators look to 'holistic review'

Industry veterans launch new biotech VC with $310M

At least 13 dead in Texas as scorching temps continue

Robert F. Kennedy is pitching centrism on health, even on abortion

hotspot

How digital tools helped lower hypertension in marginalized patients

The high personal cost of affirmative action for Black doctors

New safety details link Apellis eye drug to rare cases of blindness

No plane should take off without an EpiPen onboard

Sage hopes for a blockbuster in antidepressant now before FDA

NIH launches clinical trials and new research office for long Covid

focus

focus

leisure time

Wikipedia